Global Drug Safety and Pharmacovigilance Solution Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Drug Safety and Pharmacovigilance Solution Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Issue Tracking Solution
  • 1.2.3 Fully Integrated Solution
  • 1.2.4 Adverse Event Reporting Solution
  • 1.2.5 Drug Safety Audits Software
• 1.3 Market by Application
  • 1.3.1 Global Drug Safety and Pharmacovigilance Solution Market Share by Application: 2020 VS 2026
  • 1.3.2 BPOs
  • 1.3.3 CROs
  • 1.3.4 Pharmaceutical Companies
  • 1.3.5 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Drug Safety and Pharmacovigilance Solution Market Perspective (2015-2026)
• 2.2 Global Drug Safety and Pharmacovigilance Solution Growth Trends by Regions
  • 2.2.1 Drug Safety and Pharmacovigilance Solution Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Drug Safety and Pharmacovigilance Solution Historic Market Share by Regions (2015-2020)
  • 2.2.3 Drug Safety and Pharmacovigilance Solution Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Drug Safety and Pharmacovigilance Solution Players by Market Size
  • 3.1.1 Global Top Drug Safety and Pharmacovigilance Solution Players by Revenue (2015-2020)
  • 3.1.2 Global Drug Safety and Pharmacovigilance Solution Revenue Market Share by Players (2015-2020)
• 3.2 Global Drug Safety and Pharmacovigilance Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Drug Safety and Pharmacovigilance Solution Revenue
• 3.4 Global Drug Safety and Pharmacovigilance Solution Market Concentration Ratio
  • 3.4.1 Global Drug Safety and Pharmacovigilance Solution Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Drug Safety and Pharmacovigilance Solution Revenue in 2019
• 3.5 Key Players Drug Safety and Pharmacovigilance Solution Area Served
• 3.6 Key Players Drug Safety and Pharmacovigilance Solution Product Solution and Service
• 3.7 Date of Enter into Drug Safety and Pharmacovigilance Solution Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Drug Safety and Pharmacovigilance Solution Breakdown Data by Type (2015-2026)

• 4.1 Global Drug Safety and Pharmacovigilance Solution Historic Market Size by Type (2015-2020)
• 4.2 Global Drug Safety and Pharmacovigilance Solution Forecasted Market Size by Type (2021-2026)

5 Drug Safety and Pharmacovigilance Solution Breakdown Data by Application (2015-2026)

• 5.1 Global Drug Safety and Pharmacovigilance Solution Historic Market Size by Application (2015-2020)
• 5.2 Global Drug Safety and Pharmacovigilance Solution Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Drug Safety and Pharmacovigilance Solution Market Size (2015-2026)
• 6.2 North America Drug Safety and Pharmacovigilance Solution Market Size by Type (2015-2020)
• 6.3 North America Drug Safety and Pharmacovigilance Solution Market Size by Application (2015-2020)
• 6.4 North America Drug Safety and Pharmacovigilance Solution Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Drug Safety and Pharmacovigilance Solution Market Size (2015-2026)
• 7.2 Europe Drug Safety and Pharmacovigilance Solution Market Size by Type (2015-2020)
• 7.3 Europe Drug Safety and Pharmacovigilance Solution Market Size by Application (2015-2020)
• 7.4 Europe Drug Safety and Pharmacovigilance Solution Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Drug Safety and Pharmacovigilance Solution Market Size (2015-2026)
• 8.2 China Drug Safety and Pharmacovigilance Solution Market Size by Type (2015-2020)
• 8.3 China Drug Safety and Pharmacovigilance Solution Market Size by Application (2015-2020)
• 8.4 China Drug Safety and Pharmacovigilance Solution Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Drug Safety and Pharmacovigilance Solution Market Size (2015-2026)
• 9.2 Japan Drug Safety and Pharmacovigilance Solution Market Size by Type (2015-2020)
• 9.3 Japan Drug Safety and Pharmacovigilance Solution Market Size by Application (2015-2020)
• 9.4 Japan Drug Safety and Pharmacovigilance Solution Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Drug Safety and Pharmacovigilance Solution Market Size (2015-2026)
• 10.2 Southeast Asia Drug Safety and Pharmacovigilance Solution Market Size by Type (2015-2020)
• 10.3 Southeast Asia Drug Safety and Pharmacovigilance Solution Market Size by Application (2015-2020)
• 10.4 Southeast Asia Drug Safety and Pharmacovigilance Solution Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

• 11.1 Ennov
  • 11.1.1 Ennov Company Details
  • 11.1.2 Ennov Business Overview
  • 11.1.3 Ennov Drug Safety and Pharmacovigilance Solution Introduction
  • 11.1.4 Ennov Revenue in Drug Safety and Pharmacovigilance Solution Business (2015-2020))
  • 11.1.5 Ennov Recent Development
• 11.2 AB-Cube
  • 11.2.1 AB-Cube Company Details
  • 11.2.2 AB-Cube Business Overview
  • 11.2.3 AB-Cube Drug Safety and Pharmacovigilance Solution Introduction
  • 11.2.4 AB-Cube Revenue in Drug Safety and Pharmacovigilance Solution Business (2015-2020)
  • 11.2.5 AB-Cube Recent Development
• 11.3 Oracle
  • 11.3.1 Oracle Company Details
  • 11.3.2 Oracle Business Overview
  • 11.3.3 Oracle Drug Safety and Pharmacovigilance Solution Introduction
  • 11.3.4 Oracle Revenue in Drug Safety and Pharmacovigilance Solution Business (2015-2020)
  • 11.3.5 Oracle Recent Development
• 11.4 Extedo
  • 11.4.1 Extedo Company Details
  • 11.4.2 Extedo Business Overview
  • 11.4.3 Extedo Drug Safety and Pharmacovigilance Solution Introduction
  • 11.4.4 Extedo Revenue in Drug Safety and Pharmacovigilance Solution Business (2015-2020)
  • 11.4.5 Extedo Recent Development
• 11.5 ArisGlobal
  • 11.5.1 ArisGlobal Company Details
  • 11.5.2 ArisGlobal Business Overview
  • 11.5.3 ArisGlobal Drug Safety and Pharmacovigilance Solution Introduction
  • 11.5.4 ArisGlobal Revenue in Drug Safety and Pharmacovigilance Solution Business (2015-2020)
  • 11.5.5 ArisGlobal Recent Development
• 11.6 Sarjen Systems
  • 11.6.1 Sarjen Systems Company Details
  • 11.6.2 Sarjen Systems Business Overview
  • 11.6.3 Sarjen Systems Drug Safety and Pharmacovigilance Solution Introduction
  • 11.6.4 Sarjen Systems Revenue in Drug Safety and Pharmacovigilance Solution Business (2015-2020)
  • 11.6.5 Sarjen Systems Recent Development
• 11.7 RxLogix
  • 11.7.1 RxLogix Company Details
  • 11.7.2 RxLogix Business Overview
  • 11.7.3 RxLogix Drug Safety and Pharmacovigilance Solution Introduction
  • 11.7.4 RxLogix Revenue in Drug Safety and Pharmacovigilance Solution Business (2015-2020)
  • 11.7.5 RxLogix Recent Development
• 11.8 Sparta Systems
  • 11.8.1 Sparta Systems Company Details
  • 11.8.2 Sparta Systems Business Overview
  • 11.8.3 Sparta Systems Drug Safety and Pharmacovigilance Solution Introduction
  • 11.8.4 Sparta Systems Revenue in Drug Safety and Pharmacovigilance Solution Business (2015-2020)
  • 11.8.5 Sparta Systems Recent Development
• 11.9 United BioSource LLC (UBC)
  • 11.9.1 United BioSource LLC (UBC) Company Details
  • 11.9.2 United BioSource LLC (UBC) Business Overview
  • 11.9.3 United BioSource LLC (UBC) Drug Safety and Pharmacovigilance Solution Introduction
  • 11.9.4 United BioSource LLC (UBC) Revenue in Drug Safety and Pharmacovigilance Solution Business (2015-2020)
  • 11.9.5 United BioSource LLC (UBC) Recent Development
• 11.10 TARA (MedGenesis)
  • 11.10.1 TARA (MedGenesis) Company Details
  • 11.10.2 TARA (MedGenesis) Business Overview
  • 11.10.3 TARA (MedGenesis) Drug Safety and Pharmacovigilance Solution Introduction
  • 11.10.4 TARA (MedGenesis) Revenue in Drug Safety and Pharmacovigilance Solution Business (2015-2020)
  • 11.10.5 TARA (MedGenesis) Recent Development
• 11.11 BaseCon
  • 10.11.1 BaseCon Company Details
  • 10.11.2 BaseCon Business Overview
  • 10.11.3 BaseCon Drug Safety and Pharmacovigilance Solution Introduction
  • 10.11.4 BaseCon Revenue in Drug Safety and Pharmacovigilance Solution Business (2015-2020)
  • 10.11.5 BaseCon Recent Development
• 11.12 Indegene
  • 10.12.1 Indegene Company Details
  • 10.12.2 Indegene Business Overview
  • 10.12.3 Indegene Drug Safety and Pharmacovigilance Solution Introduction
  • 10.12.4 Indegene Revenue in Drug Safety and Pharmacovigilance Solution Business (2015-2020)
  • 10.12.5 Indegene Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer